Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"][tab title="Sponsored research"]Robert M. Califf of Cardiology has received a sub-award (P122013-499A) through the Harvard Pilgrim Health Care, Inc. for a project entitled "National Patient-Centered Clinical Research Network Coordinating Center." Total funding will be $2,218,636.
Michel Khouri of Cardiology has received a sub-award (5U10-HL105907-03) through the New York University School of Medicine for a project entitled "ISCHEMIA: International Study of Comparative Health Effectiveness with Medical and Invasive Approaches." Total funding will be $73,975.
Manesh R. Patel of Cardiology has received a sub-award through Saint Luke's Hospital (Kansas City) for a project entitled "Patient-centered Outcomes Related to Treatment practices in peripheral Arterial disease: an International Trajectory." Total funding will be $13,650.
Ying Xian of Cardiology has received an award from the American Heart Association for a project entitled "Safety and Clinical Effectiveness of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke." Total funding will be $76,947.
Rowena J. Dolor of General Internal Medicine has received an award from the Interstate Postgraduate Medical Association for a project entitled "HRT Raising Awarness-Starting the Conversation." Total funding will be $123,049.
Vance G. Fowler Jr. of Infectious Diseases has received an award (HHSN272200900023C) from the National Institutes of Health for a project entitled "Modification No. 7 - Staphylococcal Bacteremia Study." Total funding will be $458,627.
Vance G. Fowler Jr. of Infectious Diseases has received an award (HHSN272200900023C) from the National Institutes of Health for a project entitled "Mod 11 for Option 3 - Staphylococcal Bacteremia Study." Total funding will be $3,797,027.
Mehri McKellar of Infectious Diseases has received a sub-award (6X07HA00051) through the NC Department of Health and Human Services for a project entitled "Ryan White Part B Region 7 Network of Care." Total funding will be $421,335.
Jeffrey Crawford of Medical Oncology has received an award (1U10-CA180857-01) from the National Institutes of Health for a project entitled "NCI National Clinical Trials Network-Network Lead Academic Participating Sites U10."Total funding will be $2,041,800.
Ivan Spasojevic of Medical Oncology has received an award from the UT MD Anderson Cancer Center for a project entitled "Evaluation of Fosaprepitant's effect on drug metabolism in sarcoma patients receiving ifosfamide-based multi-day chemotherapy regimen." Total funding will be $59,999.
Susan B. Gurley of Nephrology has received an award (1R01-DK098382-01A1) from the National Institutes of Health for a project entitled "Actions of Angiotensin II Along the Nephron to Regulate Blood Pressure." Total funding will be $366,306.
Monica Kraft of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (5U10-HL098115-05) through the University of Arizona for a project entitled "Asthma Net Task Order #5 BARD." Total funding will be $753,724.
Jamie L. Todd of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (HHSF223200910061I) through the Harvard Pilgrim Health Care, Inc. for a project entitled "Blood-SCAN feasibility Phase 3." Total funding will be $10,120.[/tab][tab title="Industry-sponsored clinical trials"]John H. Alexander of Cardiology has received an award from the Boehringer Ingelheim Corporation for a project entitled "CARMELINA." Total funding will be $1,176,273.
John H. Alexander of Cardiology has received an award from Merck for a project entitled "ALEXA088Strony/Mahaffey ms." Total funding will be $49,693.
James P. Daubert of Cardiology has received an award from Medtronic, Inc. for a project entitled "Optimal Pacing in Patients with First-Degree AV-block." Total funding will be $34,698.
Christopher Granger of Cardiology has received an award from the Bristol-Myers Squibb Company for a project entitled "2013 Global AF RFP: A Global Effort." Total funding will be $580,000.
Kevin P. Jackson of Cardiology has received an award from Medtronic, Inc. for a project entitled "LOI – Calypso Pilot - Medtronic." Total funding will be $50,000.
Mitchell W. Krucoff of Cardiology has received an award from Cardiovascular Systems Inc. for a project entitled "CSI Coronary Orbital Atherectomy System Trial (COAST)." Total funding will be $159,494.
Eric D. Peterson of Cardiology has received an award from the American College of Cardiology Foundation for a project entitled "ACC-NCDR Partnership with Institutional Research Center." Total funding will be $636,728.
Jonathan P. Piccini of Cardiology has received an award from Medtronic, Inc. for a project entitled "Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation." Total funding will be $164,561.
Eric Velazquez of Cardiology has received an award from Pfizer, Inc. for a project entitled "Evaluate the Efficacy, Safety, and Tolerability of Daily Oral Dosing of Tafamidis Meglumine in Comparison to Placebo in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM)." Total funding will be $365,015.
Andrew J. Muir of Gastroenterology has received an award from NGM Biopharmaceuticals for a project entitled" NGM 13-0103." Total funding will be $68,556.
Andrew J. Muir of Gastroenterology has received an award from Hologic, Inc. for a project entitled "Aptima HBVQuant DX." Total funding will be $3,326,541.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from PRISM PharmaCo., Ltd for a project entitled "An Open-Label, dose-Escalation Phase I/II Study of PRI-724 for Patients with Advanced Myeloid Malignancies." Total funding will be $375,797.
Thomas L. Ortel of Hematology has received an award from DSRV Inc for a project entitled "12091912 INR Project." Total funding will be $9,544.
Marilyn J. Telen of Hematology has received an award from BioMedomics, Inc. for a project entitled "Lateral Flow Hemoglobinopathies Test Development." Total funding will be $10,067.
Rahima Zennadi of Hematology has received an award from GlaxoSmithKline for a project entitled "THEEFFICACY OF TRAMETINIB AS A TREATMENT IN OUR ANIMAL MODEL OF SICKLE CELL VASO-OCCLUSION." Total funding will be $141,898.
Sarah S. Lewis of Infectious Diseases has received an award from Cubist Pharmaceuticals, Inc. for a project entitled "The Impact of Multi-Drug Resistant Gram Negative Infections in Community Hospitals." Total funding will be $132,264.
Cameron R. Wolfe of Infectious Diseases has received an award from Ansun BioPharma, Inc for a project entitled "A Phase II Randomized Double-blind Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects with Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen (DAS-181-2-05) ." Total funding will be $271,496.
Amy P. Abernethy of Medical Oncology has received an award from the Dendreon Corporation for a project entitled "Retrospective Review Evaluating the Safety and Efficacy of the sipuleucel-T vaccine in Patients with Castrate Resistant Prostate Cancer." Total funding will be $149,361.
Andrew Armstrong of Medical Oncology has received an award from Astellas Pharma Global Development, Inc for a project entitled "STREAM - Salvage Therapeutic Radiation with Enzalutamide and ADT in Men with Recurrent Prostate Cancer." Total funding will be $573,937.
Kimberly L. Blackwell of Medical Oncology has received an award from the Novartis Pharmaceuticals Corporation for a project entitled "A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer who received no prior therapy for adv disease." Total funding will be $262,407.
Frank R. Dunphy II of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "An open label, randomized phase 3 clinical trial of Nivolumab vs therapy of investigator's choice in recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck (SCCHN)." Total funding will be $104,227.
Daniel J. George of Medical Oncology has received an award from Astellas Pharma Global Development, Inc fora project entitled "A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Enzalutamide Who Are at Potential Increased Risk of Seizure." Total funding will be $123,665.
Michael R. Harrison of Medical Oncology has received an award from Pfizer, Inc. for a project entitled "Metastatic Renal Cell Cancer Registry (MaRCC Registry)." Total funding will be $80,657.
Michael A. Morse of Medical Oncology has received an award from the Bristol-Myers Squibb Company for a project entitled "A Phase 1/2 open label study of Nivolumab monotherapy or Nivolumab combined with Ipilimumab in subjects with advanced or metastatic solid tumors." Total funding will be $104,940.
John H. Strickler of Medical Oncology has received an award from Exelixis, Inc for a project entitled "Cabozantinib (XL184) with panitumamab in KRAS wild-type metastatic colorectal cancer with pharmacodynamics studies, XL184-IST28." Total funding will be $380,032.
Lake D. Morrison of Pulmonary, Allergy, and Critical Care Medicine has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "Double blind randomized placebo controlled trial evaluating the effect of oral nintedanib." Total funding will be $127,033.
Loretta Que of Pulmonary, Allergy, and Critical Care Medicine has received a sub-award (1R43-HL117399-01A1) through Cognosci, Inc. for a project entitled "I2PP2A and Asthma." Total funding will be $88,876.
Lisa G. Criscione-Schreiber of Rheumatology and Immunology has received an award from AbbVie Inc. for a project entitled "Duke University Grand Rounds Visiting Speaker Presentation - 19906." Total funding will be $6,550.[/tab]
[/tabs]